Why biological data matters more in AI drug discovery
GSK has entered right into a analysis collaboration with British biotechnology firm Relation Therapeutics value as much as $110 million, increasing the businesses’ present work in AI-assisted drug discovery. Under the settlement, Relation will generate large-scale datasets measuring how human cells reply to genetic modifications and drug interventions. The data can be used to coach…
